Identification of gliadin presence in pharmaceutical products: appropriateness of polyclonal antibodies for detection of gliadin and other toxic prolamins

J Pediatr Gastroenterol Nutr. 1995 Nov;21(4):482-3. doi: 10.1097/00005176-199511000-00023.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies*
  • Antibody Specificity
  • Drug Contamination*
  • Gliadin / analysis*
  • Immunoassay / methods*
  • Plant Proteins / analysis*
  • Prolamins

Substances

  • Antibodies
  • Plant Proteins
  • Prolamins
  • Gliadin